Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

The podocyte as a target: cyclosporin A in the management of the nephrotic syndrome caused by WT1 mutations.

Stefanidis CJ, Querfeld U.

Eur J Pediatr. 2011 Nov;170(11):1377-83. doi: 10.1007/s00431-011-1397-6. Epub 2011 Feb 8. Review.

PMID:
21298518
2.

Effect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations.

Wasilewska AM, Kuroczycka-Saniutycz E, Zoch-Zwierz W.

Eur J Pediatr. 2011 Mar;170(3):389-91. doi: 10.1007/s00431-010-1278-4. Epub 2010 Sep 17.

3.

WT1 mutations in nephrotic syndrome revisited. High prevalence in young girls, associations and renal phenotypes.

Aucella F, Bisceglia L, De Bonis P, Gigante M, Caridi G, Barbano G, Mattioli G, Perfumo F, Gesualdo L, Ghiggeri GM.

Pediatr Nephrol. 2006 Oct;21(10):1393-8. Epub 2006 Aug 15.

PMID:
16909243
4.

Frasier syndrome: early gonadoblastoma and cyclosporine responsiveness.

Sinha A, Sharma S, Gulati A, Sharma A, Agarwala S, Hari P, Bagga A.

Pediatr Nephrol. 2010 Oct;25(10):2171-4. doi: 10.1007/s00467-010-1518-x. Epub 2010 Apr 24.

PMID:
20419325
5.

Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations.

Gellermann J, Stefanidis CJ, Mitsioni A, Querfeld U.

Pediatr Nephrol. 2010 Jul;25(7):1285-9. doi: 10.1007/s00467-010-1468-3. Epub 2010 Feb 27.

PMID:
20191369
6.

[Clinical and pathological features of Denys-Drash syndrome: report of 3 cases].

Wang HY, Sun LZ, Yue ZH, Yang J, Jiang XY, Mo Y.

Zhonghua Er Ke Za Zhi. 2012 Nov;50(11):855-8. Chinese.

PMID:
23302619
7.

A child with isolated nephrotic syndrome and WT1 mutation presenting as a 46, XY phenotypic male.

Yang Y, Feng D, Huang J, Nie X, Yu Z.

Eur J Pediatr. 2013 Jan;172(1):127-9. doi: 10.1007/s00431-012-1770-0. Epub 2012 Jul 5.

PMID:
22763603
8.

New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes.

Morrison AA, Viney RL, Saleem MA, Ladomery MR.

Am J Physiol Renal Physiol. 2008 Jul;295(1):F12-7. doi: 10.1152/ajprenal.00597.2007. Epub 2008 Apr 2. Review.

9.

Different clinical presentations of WT1 gene mutations.

Aydin M, Hakan N, Zenciroglu A, Aydog O, Okumus N.

Eur J Pediatr. 2013 Dec;172(12):1705-6. doi: 10.1007/s00431-013-2085-5. Epub 2013 Jul 9. No abstract available.

PMID:
23835858
10.

WT1 and glomerular diseases.

Niaudet P, Gubler MC.

Pediatr Nephrol. 2006 Nov;21(11):1653-60. Epub 2006 Aug 23. Review.

PMID:
16927106
11.

Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome.

Büscher AK, Kranz B, Büscher R, Hildebrandt F, Dworniczak B, Pennekamp P, Kuwertz-Bröking E, Wingen AM, John U, Kemper M, Monnens L, Hoyer PF, Weber S, Konrad M.

Clin J Am Soc Nephrol. 2010 Nov;5(11):2075-84. doi: 10.2215/CJN.01190210. Epub 2010 Aug 26. Erratum in: Clin J Am Soc Nephrol. 2012 Aug;7(8):1372-4.

12.

[WT1 mutation as a cause of progressive nephropathy in Frasier syndrome--case report].

Wasilewska A, Zoch-Zwierz W, Tenderenda E, Rybi-Szumińska A, Kołodziejczyk Z.

Pol Merkur Lekarski. 2009 Jun;26(156):642-4. Polish.

PMID:
19711733
13.

Refining the Diagnosis of Congenital Nephrotic Syndrome on Long-term Stored Tissue: c.1097G>A (p.(Arg366His)) WT1 Mutation Causing Denys Drash Syndrome.

Hillen LM, Kamsteeg EJ, Schoots J, Tiebosch AT, Speel EJ, Roemen GM, Peutz-Koostra CJ, Stumpel CT.

Fetal Pediatr Pathol. 2016;35(2):112-9. doi: 10.3109/15513815.2016.1139018. Epub 2016 Feb 16.

PMID:
26882358
14.

Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome.

Büscher AK, Beck BB, Melk A, Hoefele J, Kranz B, Bamborschke D, Baig S, Lange-Sperandio B, Jungraithmayr T, Weber LT, Kemper MJ, Tönshoff B, Hoyer PF, Konrad M, Weber S; German Pediatric Nephrology Association (GPN).

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):245-53. doi: 10.2215/CJN.07370715. Epub 2015 Dec 14.

15.

WT1 gene mutations in three girls with nephrotic syndrome.

Ismaili K, Verdure V, Vandenhoute K, Janssen F, Hall M.

Eur J Pediatr. 2008 May;167(5):579-81. Epub 2007 Jun 1.

PMID:
17541636
16.

Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.

Ladapo TA, Esezobor CI, Lesi FE.

Pan Afr Med J. 2016 Dec 29;25:258. doi: 10.11604/pamj.2016.25.258.9802. eCollection 2016.

17.

Mutations in WT1 in boys with sporadic isolated steroid-resistant nephrotic syndrome.

Yang Y, Zhao F, Tu X, Yu Z.

Genet Mol Res. 2016 Mar 11;15(1):15017559. doi: 10.4238/gmr.15017559.

18.

Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.

Gellermann J, Ehrich JH, Querfeld U.

Nephrol Dial Transplant. 2012 May;27(5):1970-8. doi: 10.1093/ndt/gfr572. Epub 2011 Oct 4.

PMID:
21976740
19.

Pediatric steroid-resistant nephrotic syndrome.

McBryde KD, Kershaw DB, Smoyer WE.

Curr Probl Pediatr Adolesc Health Care. 2001 Oct;31(9):280-307. Review. No abstract available.

PMID:
11733743
20.

Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations.

Chernin G, Vega-Warner V, Schoeb DS, Heeringa SF, Ovunc B, Saisawat P, Cleper R, Ozaltin F, Hildebrandt F; Members of the GPN Study Group.

Clin J Am Soc Nephrol. 2010 Sep;5(9):1655-62. doi: 10.2215/CJN.09351209. Epub 2010 Jul 1.

Supplemental Content

Support Center